Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+6.36%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.75B
AUM Growth
+$430M
(+8.1%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-18.82%
Top 10 Holdings %
Top 10 Hldgs %
27.15%
Holding
1,587
New
76
Increased
379
Reduced
937
Closed
183
Top Buys
| 1 |
HP
HPQ
|
+$6.72M |
| 2 |
Newmont
NEM
|
+$6.32M |
| 3 |
General Mills
GIS
|
+$6.24M |
| 4 |
TJX Companies
TJX
|
+$5.82M |
| 5 |
Ford
F
|
+$5.76M |
Top Sells
| 1 |
Iron Mountain
IRM
|
+$16.2M |
| 2 |
Apple
AAPL
|
+$15.9M |
| 3 |
Amazon
AMZN
|
+$14.5M |
| 4 |
Microsoft
MSFT
|
+$13.1M |
| 5 |
GDS Holdings
GDS
|
+$7.93M |
Sector Composition
| 1 | Real Estate | 17.47% |
| 2 | Technology | 14.61% |
| 3 | Consumer Discretionary | 9.29% |
| 4 | Healthcare | 7.36% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Alkermes
ALKS
$4.57B
| $75K | ﹤0.01% |
4,014
-2,230
| -36% | -$41.7K |
|
1202
Heron Therapeutics
HRTX
$196M
| $75K | ﹤0.01% |
4,604
-196
| -4% | -$3.19K |
|
1203
Seres Therapeutics
MCRB
$154M
| $75K | ﹤0.01% |
182
-90
| -33% | -$37.1K |
|
1204
Opko Health
OPK
$1.14B
| $75K | ﹤0.01% |
17,566
-12,172
| -41% | -$52K |
|
1205
Revolution Medicines
RVMD
$8.64B
| $75K | ﹤0.01% |
1,630
-642
| -28% | -$29.5K |
|
1206
TG Therapeutics
TGTX
$5.15B
| $75K | ﹤0.01% |
1,562
-1,568
| -50% | -$75.3K |
|
|
VBIV
1207
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $75K | ﹤0.01% |
805
-537
| -40% | -$50K |
|
1208
Acadia Pharmaceuticals
ACAD
$4.08B
| $74K | ﹤0.01% |
2,882
+298
| +12% | +$7.65K |
|
1209
ALX Oncology
ALXO
$63.2M
| $74K | ﹤0.01% |
1,010
+564
| +126% | +$41.3K |
|
1210
Immunovant
IMVT
$2.93B
| $74K | ﹤0.01% |
4,594
+2,184
| +91% | +$35.2K |
|
1211
Kura Oncology
KURA
$766M
| $74K | ﹤0.01% |
2,618
-558
| -18% | -$15.8K |
|
|
SAGE
1212
DELISTED
Sage Therapeutics
SAGE
| $74K | ﹤0.01% |
991
-962
| -49% | -$71.8K |
|
1213
Akebia Therapeutics
AKBA
$793M
| $73K | ﹤0.01% |
21,604
-20,146
| -48% | -$68.1K |
|
|
ALLK
1214
DELISTED
Allakos
ALLK
| $73K | ﹤0.01% |
633
-260
| -29% | -$30K |
|
|
BLUE
1215
DELISTED
bluebird bio
BLUE
| $73K | ﹤0.01% |
186
-54
| -23% | -$21.2K |
|
1216
Sutro Biopharma
STRO
$82.2M
| $73K | ﹤0.01% |
+3,216
| New | +$73K |
|
|
SWTX
1217
DELISTED
SpringWorks Therapeutics
SWTX
| $73K | ﹤0.01% |
988
-322
| -25% | -$23.8K |
|
1218
Allogene Therapeutics
ALLO
$260M
| $72K | ﹤0.01% |
2,028
-2,802
| -58% | -$99.5K |
|
1219
Apellis Pharmaceuticals
APLS
$3.21B
| $72K | ﹤0.01% |
1,669
-986
| -37% | -$42.5K |
|
1220
BioXcel Therapeutics
BTAI
$54.3M
| $72K | ﹤0.01% |
104
-88
| -46% | -$60.9K |
|
1221
Esperion Therapeutics
ESPR
$563M
| $72K | ﹤0.01% |
2,572
-1,664
| -39% | -$46.6K |
|
1222
Amicus Therapeutics
FOLD
$2.47B
| $72K | ﹤0.01% |
7,238
+1,252
| +21% | +$12.5K |
|
|
IMGN
1223
DELISTED
Immunogen Inc
IMGN
| $72K | ﹤0.01% |
8,846
-2,440
| -22% | -$19.9K |
|
|
GBT
1224
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $72K | ﹤0.01% |
1,772
-1,478
| -45% | -$60.1K |
|
|
DRNA
1225
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $72K | ﹤0.01% |
2,800
-384
| -12% | -$9.87K |
|